Settlement of Upside Sharing Arrangement completed

Strategic Transactions View source PDF Explain this filing

ANTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.4%Reaction day

₹957.50

prior close

₹957.70

announcement price

After-mkt

timing

Nifty Midcap 150market-0.4%-1.0% vs market

Biotechnology peers, median of 5sector+0.0%-1.4% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Midcap 150 and 1.4 pts less than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

+1.2

15m

+1.9

30m

+0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.4-0.4-1.0+0.0-1.4

Next day

-2.3-0.8-1.5+1.7-4.0

-1.8-1.0-0.7-1.2-0.5

-1.3-3.2+1.9-2.4+1.1

-4.6-3.1-1.5-3.4-1.2

-3.0-2.3-0.7-2.5-0.5

-4.0-1.2-2.8-3.6-0.3

15d

-10.3-6.3-4.1-7.6-2.7

-9.6-6.4-3.1-9.6+0.0

—————

UpDownMarket · Nifty Midcap 150Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anthem Biosciences has settled an upside sharing arrangement arising from the divestment by Viridity Tone LLP. An amount of about INR 1,276.83 million has been paid to three Upside Principal Shareholders (Ajay Bhardwaj, Ganesh Sambasivam, and K. Ravindra Chandrappa) following approval at the AGM on July 22, 2026, under a Waiver-cum-Amendment Agreement from December 30, 2024.

Likely market impact

A one-time cash payout of about INR 1,276.83 million to three key insiders, settled per a prior 2024 agreement linked to a past divestment.